Clinical trial
Comparative Evaluation of Vortioxetine Versus Other Antidepressants With Pregabalin Augmentation in Treatment-resistant Burning Mouth Syndrome: a Prospective Longitudinal Clinical Trial With Treatment Response Prediction
NCT06025474 is registered in ClinicalTrials.gov with Federico II University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparative Evaluation of Vortioxetine Versus Other Antidepressants With Pregabalin Augmentation in Treatment-resistant Burning Mouth Syndrome: a Prospective Longitudinal Clinical Trial With Treatment Response Prediction
- Lead sponsor
- Federico II University
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- January 1, 2023
- Completion date
- July 24, 2024
- Enrollment
- 203 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.